Objective
to report the 5-year clinical outcomes of Orsiro stent (biodegradable ultra-thin stent) as compared to Nobori stent (biodegradable polymer) for the treatment of coronary lesions
Study
multicentre, non-inferiority, randomised trial
Population
all-comers
Endpoints
target lesion failure as cardiac death, MI or target lesion revascularisation at 5-years
Conclusion
the 5-year target lesion failure rate did not differ between PCI treatment in all-comers with the use of Orsiro stents compared to Nobori stents
Hansen et al Circ. Interventions: 2023; 16:e012332